Stocks Forest Laboratories Inc

  • Stocks pushed higher, buoyed by gains in drug and chip stocks. Citigroup bounced back after an initial dip on disappointing results.

  • It's early, but sell the news is the mantra so far for earnings. Stock are futures down, bonds and the dollar are up this morning. The S&P 500 recorded its largest down day in almost a month last Thursday, despite a good report from Intel. In-line (Citi) or even slightly better than expected earnings (Intel) may not be good enough...

  • Wall Street investors returned from a long weekend undecided about how to trade, with stock index futures pointing to little change at the open. But earnings from Citigroup could dictate direction from the opening bell.

  • earnings_central_badge.jpg

    What follows is a roundup of corporate earnings reports for Tuesday, Jan.  19.

  • The Bureau of Labor Statistics doesn't release its official jobs report until Friday but there is lots of preamble.

  • We are putting cash back to work, said Ron Muhlenkamp, portfolio manager at The Muhlenkamp Fund, and Jeff Mortimer, CIO of Charles Schwab Investment Management.

  • EarningsCentral_20081022.jpg

    The slumping economy negatively impacted many smaller companies that reported earnings on Tuesday. The following are some firms that reported earnings before the opening bell:

  • Markets are bracing for a landslide of earnings news Tuesday and more focus on the Treasury's bank bailout plans.

  • graphic_word_ofthe_street.jpg

    The Dow rallied for a third day on Thursday, and traded above 8,000 for the first time since early February on an intra-day basis.

  • Generic drug company Forest Labs is seeing heavy call activity amid buyout rumors.

  • leerink_swann.jpg

    Forget about mergers and acquisitions (M & A). Think about partnerships and acquisitions or what Leerink Swann, which specializes in healthcare stock coverage, is calling "P & A."

  • Movement in a few key sectors could give stocks a much-needed boost.

  • Ever wonder how these people decide which stock's a buy and which is a sell? Now you know.

  • Depends on which analyst you believe. Find out who Cramer's siding with.

  • Following are the day’s biggest winners and losers. Find out why shares of Staples and Honda popped while Nokia and ConAgra dropped.

  • Scott Richter, portfolio manager of the Fifth Third Disciplined Fund, prescribes two stocks in the pharmaceuticals sector.

  • To give investors an edge, CNBC asked the market experts for their best trades now.

  • Mary Jane Matts knows a few things about "up" stocks in a "down" market, and she's sharing a couple of suggestions with CNBC.

  • The debate about whether stocks are finding a floor is gaining momentum, but traders agree it's the earnings season that will help decide the details.

  • Following are the week’s biggest winners and losers. Find out why shares of Valero and Lehman popped while State Street and Wynn dropped.